04/29/2024 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 3:26 PM | Collegium Pharmaceutical (Issuer) Smith Thomas B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:24 PM | Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:14 PM | Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 3:39 PM | Collegium Pharmaceutical (Subject) Dreyer Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 11:04 AM | Collegium Pharmaceutical (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
|
02/12/2024 5:06 AM | Collegium Pharmaceutical (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
01/19/2024 1:40 PM | BlackRock Inc. (Filed by) Collegium Pharmaceutical (Subject)
| Form SC 13G/A | |
01/18/2024 3:19 PM | Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 3:36 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:51 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:28 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:32 PM | Collegium Pharmaceutical (Issuer) Kuhlmann Shirley R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 4:00 PM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 6:40 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 9:19 AM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023 6:08 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 9:04 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:10 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:15 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 8:58 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023 11:10 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023 3:37 PM | BOHLIN GAREN G (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:38 PM | Collegium Pharmaceutical (Issuer) SANTINI GINO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:38 PM | Collegium Pharmaceutical (Issuer) Melincoff Gwen A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:39 PM | Collegium Pharmaceutical (Issuer) Fallon John A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:39 PM | Collegium Pharmaceutical (Issuer) Freund John Gordon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:40 PM | Collegium Pharmaceutical (Issuer) Heffernan Michael Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:40 PM | Collegium Pharmaceutical (Issuer) McFarlane Neil F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 3:40 PM | Balice-Gordon Rita J. (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |